Melt Pharmaceuticals Names Experienced Executive Brad Osborne as Chief Financial Officer

NASHVILLE, Tenn.--(BUSINESS WIRE)--Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company developing first‑in‑class medicines for sedation and analgesia, today announced the addition of Brad Osborne as Chief Financial Officer. Osborne brings 20 years of extensive finance and accounting experience. Prior to joining Melt Pharmaceuticals, Osborne worked for 10 years with Precigen, Inc. (formerly Intrexon Corporation), a Nasdaq-listed discovery and clinical-stage biopharmaceutical comp